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Özet
AMAÇ: Bu çalışma alkolik olmayan yağlı karaciğer (NAFLD) olgularının biopsi 
öncesi değerlendiriminde elastografinin etkinliğini araştırmak için planlandı.
GEREÇ VE YÖNTEMLER: Radyoloji bölümünde 18 NAFLD hastası B mod ultra-
son ile incelendikten sonra elastografi ile değerlendirildi . Olguların hiçbirinde 
kronik karaciğer hastalığı yoktu. Yaşları 35 ila 71 arasında değişen 8 erkek hasta 
ile 10 kadın hasta çalışmaya dahil edildi ( ortalama 54±9.5). Son 6 ay içerisindeki 
biyokimyasal değerlendirmeleri de kayıt altına alındı. Karaciğer dalak ile karşılaş-
tırılarak ekojenite artışına göre I., II. ve III. derecelerde ile sınıflandıırldı. B mod ve 
elastografi değerlendirilmesi Hitachi HI VISION Preirus sistemi ile 6.5 MHz lineer 
prob ile yapıldı. 
BULGULAR: Olguların %55,6’sı kadın, %44’ ü erkek idi. Evre I NAFLD olgularının 
tümü kadın idi (n:5). Evre III olgularının sadece %33,3’ü kadın idi (n:2). Gruplar 
arası hepatosteatoz evresi göz önüne alındığında elastografi sonuçları arasında 
fark saptanmadı. Biyokimyasal değerler ve hepatomegali ölçüm değerleri göz 
önüne alındığında GGT ve hepatomegali ölçümleri gruplar arası farklılık göster-
mekte idi (p:0.015). 
SONUÇ: Bu çalışmada, B mod ultrasonda sıklıkla kullanılan hepatosteatoz ev-
releme sistemi elastografi tekniği ile doğrulanamadı. Böylelikle NAFLD tanısı ile 
biyopsi gereken ile gerekmeyen takipteki olgular arasında ayrım yapılamadı. Bu 
veri transient elastografi bulgularından oldukça farklı idi.
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Abstract
OBJECTIVE: This study evaluates whether dynamic elastography could better 
characterize and differentiate the non-alcoholic fatty liver disease (NAFLD) and 
patient pool for biopsy.
MATERIALS AND METHODS: 18 patients with NAFLD were examined by ul-
trasound (US) and elastography at the Department of Radiology. The patients, 
none of whom had any chronic liver disease, were 54±9.5 (35-71) years old (8 
men; 10 women). Biochemical markers were evaluated. Patients with high liver 
echogenicity were classified as Stage III NAFLD. B-mode US equipment includes 
a Hitachi HI VISION Preirus system with an embedded elastography (EL) module 
(Hitachi Medical Systems Europe) and 6.5 MHz linear probe. 
RESULTS: Of the cases, 55.6% were female and 44.4% were male. All cases with 
Stage I NAFLD were female (n:5). Only 33.3% of the cases with Stage III NAFLD 
were female (n:2). According to the results of elastography, no intergroup dif-
ference was differentiated when the stages of NAFLD were compared. When 
biochemical and hepatomegaly values were considered, differences were only 
detected in GGT and hepatomegaly values among the NAFLD groups (p:0.015). 
CONCLUSION: In the study, the stages of hepatosteatosis could not be differ-
entiated with the EL examination. Therefore, it was thought to be of no benefit 
to the selection.
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Introduction
The non alcoholic fatty liver disease (NAFLD) is still the leading cause of chronic liver injury throughout the world (1, 2). The range of 
histolopathological morphology differs widely, usually from a simple nonprogressive steatosis to parenchymal chronic necrosis, which 
may in turn progresses to become hepatocellular carcinoma (3, 4).
Since the rate of hepatitis is high in our country, the interest in patients with NAFLD remains of secondary importance.
The gold standart to diagnose of NASH in the liver has been liver biopsy (1, 4, 5).
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Menghini first defined liver biopsy in 1958, and it has now been the gold 
standard method for fibrosis. However, it is an interventional method 
with high morbidity (6). In addition, intra- and interobserver disagree-
ments are high in the evaluation of fibrosis (7). Therefore, fewer invasive 
methods have been developed. Measurement of the liver elasticity is 
valuable for the diagnoses of non-alcoholic steatohepatitis and fibrosis 
(8, 9). Yoneda previously mentioned that transient sonoelastography 
could be used to find fibrosis in patients with NAFLD (10, 11).
The findings of liver palpation - part of the examination - are subjec-
tive, and while elasticity increases with fat accumulation, it can be 
felt through palpation that liver stiffness increases and its elasticity 
decreases in fibrosis. With the method of ultrasound elastography, 
the mechanically applied pressure on organs such as breast, pros-
tate, and thyroid causes deformation and the resulting elasticity is 
measured. The tissue stiffness can be determined with the state of 
the tissue resistance to compression (12). 
Materials and Methods
A total of 18 consecutive patients with NAFLD were examined by 
transabdominal ultrasound and transabdominal ultrasound elastog-
raphy in a 1-month period in 2013. In this period, the patients were 
examined at 2 stages. At the Department of Radiology, 9 cases were 
examined at Stage 1 that comprised the first 15 days and 9 cases 
at Stage 2 that comprised the other 15 days. The patients, none of 
whom had any chronic liver disease, were 54±9.5 (35-71) years old (8 
men; 10 women). Aspartate aminotransferase, alanine aminotrans-
ferase, gamma-glutamyltransferase and fasting blood sugar were 
evaluated. All cases were compared according to spleen echogenic-
ity by means of B-mode ultrasound; the highness of liver echogenic-
ity was evaluated; and the NAFLD was classified into 3 stages accord-
ing to spleen echogenicity. 
B-mode Ultrasound equipment includes a Hitachi HI VISION Preirus 
ultrasound system with embedded elastography module (Hitachi HI 
VISION Preirus, Hitachi, Zug, Switzerland) and 6.5 MHz linear probe. 
The same conditions of brightness, contrast and gain of the ultra-
sound system were used in all examinations. All examinations were 
done by two radiologists with different degrees of experience in US. 
The US probe was placed in a convenient right intercostal space and 
elastography information was gathered during breath holding at the 
end of the expiration phase. Three movies were recorded by each ex-
aminer for every patient with the region of interest set to include the 
liver and surrounding tissue (Figure 1, 2). The movies were stored un-
compressed at the maximum quality for further accurate computer 
enhanced analysis.
Analysis of computer enhanced elastography movies
The elasticity of tissue was reconstructed within the region of interest 
and translated into a color signal that overlay the grey scale image. 
To visualize tissue elasticity patterns, different elasticity values were 
marked with different colors (on a scale of 1 to 256). The system was 
set up to use a hue color map (red / green / blue) where hard tissue 
areas were marked with dark blue, medium hard tissue areas with 
cyan, intermediate tissue areas with green, medium soft tissue areas 
with yellow, and soft tissue areas with red. 
The quality of tissue compression was indicated by sinusoidal graphic 
scale within the image.
Each recorded elastography movie was subjected to a computer en-
hanced dynamic analysis using a public domain Java-based image 
processing tool (ImageJ). The images are processed in this program 
and dynamically analyze the individual hue histograms of each frame 
from an elastography movie. Every color frame was transformed into 
the numerical form (Area and Mean) in histograms.
Statistical analysis
The Statistical Package for the Social Sciences (SPSS) 21 (SPSS, Chica-
go, IL) program was used to analyze the data. The conformity of the 
univariate data with the normal distribution was examined by con-
sidering the Kolmogorov-Smirnov test, the Shapiro-Wilk test, and the 
coefficients of Variation, and parametric methods were employed to 
analyze the variables with a normal distribution, whereas nonpara-
metric methods were used to analyze the variables without any nor-
mal distribution. One-Way Anova (Robust Test: Brown-Forsythe) was 
used to compare the independent multiple groups with each other, 
and the LSD tests were employed for the post-hoc analyses. After the 
main factors of the variables had been taken under control, the Partial 
Correlation test was used to examine the correlations of the variables 
with each other. The Monte Carlo simulation technique of the Pear-
son’s Chi-Square Test was employed to compare the categorical data. 
Figure 1. Elastography findings of Stage I hepatosteatoz 
Figure 2. Elastography findings of Stage III hepatosteatoz 
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The performances between the new variable we formed as AreaAr-
ea/mean with the real classification and the predicted classification 
were expressed with sensitivity and specificity. The quantitative data 
were provided as mean±std (standard deviation) and median±IQR 
(Interquartile Range) values in the tables. The categorical data were 
expressed in n (number) and percentages (%). The data were exam-
ined at the 95% confidence level, and the p value smaller than 0.05 
was considered significant. The information and experience of www.
tibbiistatistikci.com and www.medicalstatistic.com were utilized in 
the statistical evaluations.
When the cases were diagnosed according to the one with the high-
est average color score so as to determine the real diagnosing effi-
ciency of the average color scores obtained in the ImageJ program, 
none of the 18 cases turned out red (0% Specificity). It was classified 
as blue in 13 people (72.2%) and green in 5 people (27.8%). 
The area under the curve was calculated in this program. According-
ly, when reclassified, specificity was classified as 38.9% for red in 7, as 
38.9% for blue in 7, and as 22.2% for green in 4 of 18 cases. 
Of both methods, the rate of diagnosing according to the area under 
the curve was seen to be more successful. However, no significant 
classification could be obtained according to all patients. 
When the success of the new classification with the data obtained by 
dividing the area under the curve by the Mean value was examined 
for a more successful classification, the accurate classification was 
reached with 100% specificity in all of the 18 cases. 
When the classification performances were evaluated, the best 
classification was the classification according to the area under the 
curve/Mean and it was detected to be more successful than the other 
methods thanks to its differentiating with 100% accuracy.
Results
Of the cases, 55.6% were female (n:10) and 44.4% (8) were male. All 
cases with Stage I NAFLD were female (n:5). Only 33.3% of the cases 
with Stage III NAFLD were female (n:2). The descriptive values of the 
cases that participated in the study are presented in Table 1. 
According to the results of elastography, no intergroup difference 
was differentiated when the stages of the NAFLD were compared. 
When the blood biochemical values (AST, ALT, FBG, and GGT) and 
hepatomegaly values were taken into consideration, differences 
among the NAFLD groups were only detected in the GGT and hep-
atomegaly values. This difference in the GGT values was between the 
groups with Stages I and II, whereas the difference in the hepato-
megaly level was between the groups with Stages II and III (Table 2). 
When the correlation results were considered, a high correlation was 
only detected between GGT and the stages of the NAFLD (r=0.614; 
p:0.015). No correlation was differentiated between the elastography 
values and the stages of the NAFLD.
Discussion
Strain elastography (SE), also termed quasi-static strain imaging, has 
been developed by several manufacturers; however, only Hitachi ul-
trasound system has been evaluated for use in liver (13).
In our study, the B-mode US findings and the results of Elastography 
do not agree with each other in hepatosteatosis. From this, we con-
cluded that both techniques should be re-examined for cases with 
NAFLD. In the study, it turned out that the elastography technique 
failed to clearly differentiate between the degrees of hepatosteato-
sis, which could be differentiated by B-mode Ultrasound. In the litera-
ture, Argo et al. reported that 37.6% of the patients progressed to the 
higher fibrosis stage, that 41.6% exhibited no change, and that 20.8% 
exhibited improvement in fibrosis with follow-up biopsies (14). Suzu-
ki et al. (15) followed patients with NAFLD in a 4-year period by using 
FibroScan and reached the same findings. Their study showed that 
transient elastography could be a useful tool to monitor the severity 
of hepatic fibrosis in patients with NAFLD. Furthermore, Yoneda et al. 
found a positive correlation between liver stiffness and the severity 
of liver fibrosis in patients with NAFLD with the technique of tran-
sient elastography (10).
The limitation of this study is that the cases with normal liver func-
tion tests and the ‘normal’ cases with no hepatosteatosis were not 
included in the study. In addition, the regions of interest (ROI) of the 
elastography movies could not be entirely filled due to the obesity 
of the cases. 
In their study where they employed the technique of transient elas-
tography, Petta et al. contributed to the literature on this subject and 
indicated that the Body Mass Index was the major determinant of 
these diagnostic errors in predicting significant and severe fibrosis by 
either overestimating or underestimating the stage of fibrosis (16). 
We also had difficulty in carrying out the technique in the patients 
with a high BMI in our study.
In their transient elastography study, Suzuki et al. did not use B-mode 
US in the staging of the cases with NAFLD. In our study, we tried to con-
Table 1. The descriptive values of the cases
   NAFLD  Total p
  Stage I Stage II Stage m
Sex Women n(%) 5 3 2 10 0,069
 Man n(%) 0 4 4 8 
Age Mean±Ss. 55,4±9,21 55,71±11,12 50,83±8,7 54±9,55 0,626
 Maximum- Minimum 64-40 7 1-35 65-41 7 1-35 
Pearsou Chi-Square Test(moute Carlo) - OneWay ANOVA(Robust Test:Brown-Forsythe) Ss.:Stanclart Deviation
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sider the agreement between the B-mode US findings and the elas-
tography findings and did not detect any relationship between them. 
Wong et al. (17) and Lupsor et al. (18) evaluated fibrosis and cirrhosis 
in cases with NAFLD by means of transient elastography and revealed 
that data equivalent to biopsy could be collected. In our study, we 
could not reach this result with the method of strain elastography.
In conclusion, the evidence with this approach is still too limited to 
allow recommendation for its clinical use, according to the EFSUMB 
recommendations (13). We also reached this result in our study.
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